The report states that medical cannabis makes up the biggest part of the market segment, taking up most of the revenue shares based on 2019 figures at 71%. This is attributed to the increasing adoption of cannabis as a legitimate alternative to pharmaceuticals, especially for treating life-threatening conditions including cancer, Parkinson’s disease, Alzheimer’s disease, arthritis, and neurological disorders among others. There is also a rising demand for effective painkillers as well as chronic pain medications for the elderly, and this is where much product demand is expected to be seen.
Twenty years after Harold & Kumar, the actor talks to High Times about meeting Cheech…
Fat Nugs Magazine’s Kids and Cannabis issue tackled a tough but necessary conversation. A partner…
On April 23, 2026, the Trump administration moved medical marijuana from Schedule I to Schedule…
The Acting Attorney General is getting the ball rolling on the rescheduling of cannabis from…
Based on the researchers’ findings, individuals who consumed cannabis drinks reduced alcohol intake by nearly…
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…